{"transactions":[{"id":4626520,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:25:52.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23439,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As of immediately prior to the Effective Time, each award of performance restricted stock units of the Issuer (a \"Company PSU Award\") that was outstanding as of immediately prior to the Effective Time was cancelled in exchange for the right to receive an amount in cash, without interest, equal to (i) the Per Share Cash Consideration multiplied by (ii) the number of Ordinary Shares with respect to such Company PSU Award that remained outstanding and unreleased as of immediately prior to the Effective Time, plus (iii) one CVR for each Ordinary Share underlying such Company PSU Award."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001961289-26-000011","document":"form4-09252026_120949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1961289/000196128926000011/form4-09252026_120949.xml","form_type":"4"}},{"id":4626519,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:25:52.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":108436,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, pursuant to the Merger Agreement, each award of restricted stock units of the Issuer (a \"Company RSU Award\") that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the Per Share Cash Consideration multiplied by (ii) the number of Ordinary Shares underlying such Company RSU Award (subject to any required tax withholdings as provided in the Merger Agreement) plus (iii) one CVR for each Ordinary Share underlying such Company RSU Award."}],"balance_after":23439,"source":{"system":"sec-edgar","filing":"0001961289-26-000011","document":"form4-09252026_120949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1961289/000196128926000011/form4-09252026_120949.xml","form_type":"4"}},{"id":4626518,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:25:52.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":204966,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 23, 2026, pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated June 28, 2026, by and among the Issuer, Zymeworks Inc. (\"Parent\"), and Zymeworks Merger Sub 1, a wholly owned subsidiary of Parent, the Issuer became a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), pursuant to the Merger Agreement, each ordinary share, par value $0.00001 per share, of the Issuer (\"Ordinary Share\") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive (i) $17.00 in cash, without interest (the \"Per Share Cash Consideration\") and (ii) one contingent value right (a \"CVR\"). Each CVR represents a non-tradeable contractual contingent right to receive cash payments based on the achievement of certain commercial milestones following the Effective Time."}],"balance_after":131875,"source":{"system":"sec-edgar","filing":"0001961289-26-000011","document":"form4-09252026_120949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1961289/000196128926000011/form4-09252026_120949.xml","form_type":"4"}},{"id":677109,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-08-24T22:07:23.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8112,"price":16.95,"value":137498.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":336841,"source":{"system":"sec-edgar","filing":"0001961289-26-000008","document":"form4-08242026_100819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000196128926000008/form4-08242026_100819.xml","form_type":"4"}},{"id":765408,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-05-22T22:25:10.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8670,"price":16.55,"value":143488.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":344953,"source":{"system":"sec-edgar","filing":"0001961289-26-000006","document":"form4-05222026_100506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000196128926000006/form4-05222026_100506.xml","form_type":"4"}},{"id":815674,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-04-03T22:08:18.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":353623,"source":{"system":"sec-edgar","filing":"0001961289-26-000004","document":"form4-04032026_100414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000196128926000004/form4-04032026_100414.xml","form_type":"4"}},{"id":883976,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-02-25T00:40:51.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":20672,"price":19.66,"value":406411.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":316123,"source":{"system":"sec-edgar","filing":"0001961289-26-000002","document":"form4-02252026_120248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000196128926000002/form4-02252026_120248.xml","form_type":"4"}},{"id":989690,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-11-24T23:16:59.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":18627,"price":17.9,"value":333423.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":336795,"source":{"system":"sec-edgar","filing":"0001961289-25-000006","document":"form4-11242025_111155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000196128925000006/form4-11242025_111155.xml","form_type":"4"}},{"id":1057566,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-08-22T22:07:07.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9368,"price":13.39,"value":125437.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":355422,"source":{"system":"sec-edgar","filing":"0001415889-25-022801","document":"form4-08222025_100803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588925022801/form4-08222025_100803.xml","form_type":"4"}},{"id":1136711,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-05-22T22:42:52.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9348,"price":9.45,"value":88338.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":364790,"source":{"system":"sec-edgar","filing":"0001415889-25-014261","document":"form4-05222025_100548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588925014261/form4-05222025_100548.xml","form_type":"4"}},{"id":1226483,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-03-04T23:11:25.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":374138,"source":{"system":"sec-edgar","filing":"0001415889-25-006679","document":"form4-03042025_110322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588925006679/form4-03042025_110322.xml","form_type":"4"}},{"id":1248910,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-02-25T00:30:34.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":13751,"price":9.66,"value":132834.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":299138,"source":{"system":"sec-edgar","filing":"0001415889-25-005353","document":"form4-02252025_120230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588925005353/form4-02252025_120230.xml","form_type":"4"}},{"id":1353818,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-22T23:09:30.000Z","date":"2024-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8477,"price":9.97,"value":84515.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":312889,"source":{"system":"sec-edgar","filing":"0001415889-24-027571","document":"form4-11222024_111127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924027571/form4-11222024_111127.xml","form_type":"4"}},{"id":1424994,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-08-23T00:07:49.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8635,"price":8.22,"value":70979.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":321366,"source":{"system":"sec-edgar","filing":"0001415889-24-022090","document":"form4-08232024_120846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924022090/form4-08232024_120846.xml","form_type":"4"}},{"id":1505084,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-05-22T22:08:12.000Z","date":"2024-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8635,"price":9.1,"value":78578.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":330001,"source":{"system":"sec-edgar","filing":"0001415889-24-014139","document":"form4-05222024_100507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924014139/form4-05222024_100507.xml","form_type":"4"}},{"id":1547571,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-04-04T22:15:26.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment."}],"balance_after":338636,"source":{"system":"sec-edgar","filing":"0001415889-24-010326","document":"form4-04042024_100421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924010326/form4-04042024_100421.xml","form_type":"4"}},{"id":1624648,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-02-23T01:11:58.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":17036,"price":8.92,"value":151961.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":238636,"source":{"system":"sec-edgar","filing":"0001415889-24-004966","document":"form4-02232024_010249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924004966/form4-02232024_010249.xml","form_type":"4"}},{"id":1730782,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-11-22T23:14:16.000Z","date":"2023-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6187,"price":10.37,"value":64159.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":255672,"source":{"system":"sec-edgar","filing":"0001415889-23-015452","document":"form4-11222023_111102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923015452/form4-11222023_111102.xml","form_type":"4"}},{"id":1799424,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-08-22T22:17:08.000Z","date":"2023-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":7114,"price":9.7,"value":69005.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":261859,"source":{"system":"sec-edgar","filing":"0001415889-23-012520","document":"form4-08222023_100801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923012520/form4-08222023_100801.xml","form_type":"4"}},{"id":1880761,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-05-23T23:46:24.000Z","date":"2023-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8744,"price":11.21,"value":98020.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":268973,"source":{"system":"sec-edgar","filing":"0001415889-23-008674","document":"form4-05232023_110519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923008674/form4-05232023_110519.xml","form_type":"4"}},{"id":1971668,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-03-04T01:38:52.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":277717,"source":{"system":"sec-edgar","filing":"0001415889-23-004275","document":"form4-03042023_010338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923004275/form4-03042023_010338.xml","form_type":"4"}},{"id":1998652,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20249,"kind":"person","name":"Sawaf Aziz","position":1,"cik":"0001961289","reported_name":"Sawaf Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-02-23T00:27:19.000Z","date":"2023-02-20","kind":"tax_withholding","acquired":false,"shares":6783,"price":10.44,"value":70814.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":197717,"source":{"system":"sec-edgar","filing":"0001415889-23-003075","document":"form4-02232023_120258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923003075/form4-02232023_120258.xml","form_type":"4"}}]}